Medroxyprogesterone acetate

Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression

Items (National)
15.2K
NHS Cost
£585.6K
Practices
1,720
Avg per Practice
9

Overview

Medroxyprogesterone acetate is prescribed by 1,720 GP practices across England. In the last 12 months, 15,175 items were prescribed at a total cost of £585,557 to the NHS. It is classified under BNF Chapter Malignant Disease and Immunosuppression, Section Sex hormones and hormone antagonists in malignant disease.

Monthly Prescribing Trend

No monthly data available.

Prescribing by Area

AreaItemsPracticesAvg/Practicevs National
S 737 37 20 +126.1% ▲
L 519 38 14 +55.7% ▲
NG 455 24 19 +115.9% ▲
EX 434 18 24 +173.9% ▲
NE 335 16 21 +137.5% ▲
PE 288 17 17 +92.0% ▲
WA 281 18 16 +77.3% ▲
DN 277 17 16 +85.2% ▲
E 273 15 18 +106.8% ▲
IP 256 12 21 +142.0% ▲
DH 250 9 28 +215.9% ▲
CH 246 14 18 +100.0% ▲
TN 208 14 15 +69.3% ▲
BH 202 10 20 +129.5% ▲
TS 202 10 20 +129.5% ▲
ME 197 13 15 +72.7% ▲
IG 196 7 28 +218.2% ▲
CM 181 10 18 +105.7% ▲
LS 169 11 15 +75.0% ▲
RM 158 8 20 +125.0% ▲
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.